Power Law company profile

Tevogen Bio

Biotech & Life Sciences · Metuchen, United States · Founded 2020 Unicorn

Clinical-stage specialty immunotherapy company leveraging ExacTcellTM technology platform to harness the power of CD8+ cytotoxic T lymphocytes to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders

Valuation

$1.20B

Market cap · 2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

1 investor on Tevogen Bio's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 1 investor entered at this stage

Hcmpllc

Global footprint

Where Tevogen Bio has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States92.8%

🇨🇦 Canada7.2%

2 countries shown

Web traffic by country

9.4K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Patent intelligence

$168k patent portfolio · 3 active families

Estimated portfolio value

$168k

0.01% of market cap · 202.3× smaller than top peer Centessa Pharmaceuticals ($34M)

3 active patent families

Where Tevogen Bio innovates PeptideCytotoxic T cellMolecular biologyCD3Pharmaceutical drug

Where Tevogen Bio concentrates vs peers

Each axis is a top-10 topic across Tevogen Bio and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Tevogen Bio

An AI-synthesized read of the highest-engagement posts about Tevogen Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tevogen Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles